Department of Obstetrics, Taikang Tongji (Wuhan) Hospital, Wuhan, 430050, China.
Department of Gynaecology, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, 518108, China.
Biochem Biophys Res Commun. 2021 Dec 31;585:177-184. doi: 10.1016/j.bbrc.2021.11.003. Epub 2021 Nov 6.
Cervical squamous cell carcinoma (CESC) is the most common cancer type of cervical cancer, which threatens women's life seriously. LncRNA DGUOK-AS1has been reported to promote the biologic processes of CESC. We aim to figure out the role of DGUOK-AS1-miR-499a-5p-SPRR1B axis in modulating the CESC progression in vitro.
The levels of DGUOK-AS1, miR-499a-5p, and SPRR1B in CESC tissues and cells were examined by RT-qPCR. The interaction of DGUOK-AS1-miR-499a-5p-SPRR1B was verified by luciferase assay. Inhibition of DGUOK-AS1, miR-499a-5p, and SPRR1B was applied for exploring the biological function based on detection of cell viability, proliferation, migration, and apoptosis in CESC SiHa and HeLa cells.
DGUOK-AS1 and SPRR1B expressions were obviously elevated, whereas the expression of miR-499a-5p was reduced in both CESC tissues and cells. Silencing of DGUOK-AS1 attenuated cell growth and boosted apoptosis of CESC cells. Notably, DGUOK-AS1 inhibited miR-499a-5p to release SPRR1B, which significantly accelerated the development of CESC.
DGUOK-AS1sponging miR-499a-5p facilitated CESC cells progression by releasing SPRR1B in vitro. It provides a new sight for the treatment of CESC patients involving DGUOK-AS1-miR-499a-5p-SPRR1B.
宫颈鳞状细胞癌(CESC)是宫颈癌最常见的癌症类型,严重威胁着女性的生命。已有研究报道长链非编码 RNA(lncRNA)DGUK-AS1 可促进 CESC 的生物学进程。本研究旨在探讨 DGUK-AS1/miR-499a-5p/SRR1B 轴在体外调节 CESC 进展中的作用。
采用 RT-qPCR 检测 CESC 组织和细胞中 DGUK-AS1、miR-499a-5p 和 SPRR1B 的水平。通过荧光素酶报告实验验证 DGUK-AS1/miR-499a-5p/SRR1B 的相互作用。应用 DGUK-AS1、miR-499a-5p 和 SPRR1B 抑制剂,检测 CESC SiHa 和 HeLa 细胞中的细胞活力、增殖、迁移和凋亡,以探讨其生物学功能。
DGUK-AS1 和 SPRR1B 的表达明显上调,而 miR-499a-5p 的表达在 CESC 组织和细胞中均降低。DGUK-AS1 沉默可减弱 CESC 细胞的生长并促进其凋亡。值得注意的是,DGUK-AS1 抑制 miR-499a-5p 释放 SPRR1B,显著加速了 CESC 的发展。
DGUK-AS1 通过海绵吸附 miR-499a-5p 释放 SPRR1B,促进 CESC 细胞在体外的进展。这为涉及 DGUK-AS1/miR-499a-5p-SRR1B 的 CESC 患者的治疗提供了新的思路。